Image Credit: Virginia Innovation Partnership Corporation
RICHMOND, Va. — August 13, 2025 — Virginia is staking its claim as one of America’s next great life science leaders. With a deep bench of research universities, a growing network of accelerators and venture funds, and a calendar packed with biotech gatherings, the Commonwealth is moving decisively to turn scientific breakthroughs into high-growth companies.
This week, Governor Glenn Youngkin announced Lab-to-Launch, a first-of-its-kind, statewide commercialization effort designed to fast-track innovations from university labs into the marketplace. Backed by the Virginia Innovation Partnership Corporation (VIPC) and in partnership with six R1 research universities—Lab-To-Launch was developed through a collaborative effort among VIPC and Virginia’s R1 universities — University of Virginia, Virginia Tech, Virginia Commonwealth University, Old Dominion University, and William & Mary —the initiative aims to double the number of startups spun out from Virginia’s universities each year.
At the core of Lab-to-Launch are several measures designed to break through traditional commercialization bottlenecks:
- Fast-Track Licensing — Virginia’s first standardized, streamlined license for intellectual property developed at participating universities.
- Early-Stage Funding — VIPC commercialization grants of up to $50,000 to help innovators cover prototyping, regulatory, and market-entry costs.
- Entrepreneur-in-Residence Network — Industry veterans embedded on campuses to guide faculty and students through the startup process.
- Statewide IP Catalog — An online, open-access database showcasing university technologies ready for licensing or investment.
- Venture Capital Connectivity — Integration with VIPC’s Invest platform to match spin-outs with private capital sources.
“Virginia is home to world-class research university institutions,” Governor Youngkin said. “We are moving at the speed of business to accelerate commercialization pathways for university technology startups.” VIPC CEO Joe Benevento added that the program “cements Virginia’s national leadership” in innovation-driven economic development.
A Rising Biotech and Innovation Hub
The Lab-to-Launch initiative comes at a moment when Virginia’s life sciences sector is gaining critical mass. Across the state, stakeholders are building infrastructure and programs to make the Commonwealth a fertile ground for biotech startups.
In Richmond, Activation Capital—a leading innovation ecosystem builder—has launched the Pioneer Connect Program, an integrated platform providing financial, legal, lab, and networking resources to life science founders. This builds on its Frontier BioHealth accelerator, which graduated 10 startups last year spanning pharmaceuticals, diagnostics, medical devices, and consumer health, and the Start-the-Journey Pre-Accelerator, which helps early-stage biotech entrepreneurs prepare for commercialization.
These efforts, combined with increasing private-sector engagement, are positioning Virginia as a bridge between the DC-Maryland biotech powerhouse to the north and North Carolina’s Research Triangle to the south. With a growing base of venture activity, wet lab space, and specialized talent, Virginia is no longer a “fly-over” state in the bioeconomy—it’s becoming a destination.
From Lab Bench to Market Launch
For Virginia’s scientists, the Lab-to-Launch program promises more than funding—it offers a clear pathway from academic discovery to market adoption. By uniting the commercialization offices of six universities under a shared process, the state aims to cut the red tape that often slows down technology transfer.
The initiative is also designed to make Virginia more competitive in attracting federal R&D dollars, corporate partnerships, and venture investment. With an expanding entrepreneurial culture and a focus on speed, collaboration, and accessibility, the Commonwealth’s life science sector is poised for its next stage of growth.
Get Involved: Upcoming Life Sciences & Startup Events in Virginia
For researchers, entrepreneurs, investors, and job seekers eager to plug into Virginia’s momentum, the fall calendar is full of opportunities:
- Beer & Biotech (RBTC) — Aug 20
- Startup World Cup Virginia Qualifier — Aug 21
- Founders on the Brain: Case Studies in Healthcare Entrepreneurship — Aug 26
- Women Building Bio 2025 — Sept 17
- 4th Annual BioDiscovery Summit — Sept 18
- BioHealth Capital Region Forum — Sept 23–24
- 2025 Accelerate Investor Conference — Nov 5–6, George Mason University
These gatherings aren’t just networking opportunities—they’re where the next generation of Virginia biotech companies will be formed, funded, and scaled.
Virginia’s life sciences rise isn’t on the horizon—it’s happening now. With Lab-to-Launch in motion, Activation Capital’s programs in place, and a robust lineup of events, the Commonwealth is sending a clear signal to scientists, founders, and investors alike: bring your ideas here, and we’ll help you take them to marke
